CoChat
Sign Up
Cited by 364T-cell and B-cell ImmunologyGenetics, Aging, and Longevity in Model OrganismsArtificial Immune Systems Applications

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

Thymic involution and rising disease incidence with age

Open access
Palmer, Sam, Albergante, Luca, Blackburn, Clare C., Newman, T. J.·2018·Proceedings of the National Academy of Sciences
DOI 10.1073/pnas.1714478115PMC PMC5828591
Open this paper in CoChat — free accountOpen PDF

Abstract

Significance: Understanding the risk factors of carcinogenesis is a major goal of biomedical research. Historically, the focus has been on the role of somatic mutations, and the reason for cancer typically occurring late in life is predominantly attributed to a gradual accumulation of such mutations. We challenge that view and propose that the decline of the immune system is the primary reason why cancer is an age-related disease. The immunological model featured here captures risk profiles for many cancer types and infectious diseases, suggesting that therapies reversing T cell exhaustion or restoring T cell production will be promising avenues of treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1714478115

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Declining T cell production leads to increasing disease incidence. Our model assumes that immunogenic cells arise with the same probability at any age, and, after a period of being targeted, the population may overwhelm the immune system by crossing an immune escape threshold. This threshold is assumed to be proportional to T cell production, which decreases with age. This provides a prediction for the possible forms of disease incidence curves.
Fig. 1. Declining T cell production leads to increasing disease incidence. Our model assumes that immunogenic cells arise with the same probability at any age, and, after a period of being targeted, the population may overwhelm the immune system by crossing an immune escape threshold. This threshold is assumed to be proportional to T cell production, which decreases with age. This provides a prediction for the possible forms of disease incidence curves.CC BY-NC-ND · PubMed Central
Fig. 2. Infectious disease incidence. Log-linear plots of incidence (per 100,000 person-years) by age group for all ABC bacterial infections, West Nile virus (WNV) disease, and Influenza A, ordered from best fit to worst. Bacterial and viral diseases are shaded yellow and green, respectively. The two-parameter IM-II is in red, while the one-parameter IM-I is in orange. Incidence often decreases initially from birth due to an underdeveloped immune system in infants; therefore, models are fitted only to data points for ages greater than 18 y. Error bars show 99% CIs for all diseases.
Fig. 2. Infectious disease incidence. Log-linear plots of incidence (per 100,000 person-years) by age group for all ABC bacterial infections, West Nile virus (WNV) disease, and Influenza A, ordered from best fit to worst. Bacterial and viral diseases are shaded yellow and green, respectively. The two-parameter IM-II is in red, while the one-parameter IM-I is in orange. Incidence often decreases initially from birth due to an underdeveloped immune system in infants; therefore, models are fitted only to data points for ages greater than 18 y. Error bars show 99% CIs for all diseases.CC BY-NC-ND · PubMed Central
Fig. 3. Cancer incidence. Log-linear plots of incidence (per 100,000 person-years). Data taken from SEER (11). (A and B) Some cancer types rise exponentially fitting IM-I (A), while some cancer types rise like power laws, although can still be fit by IM-II (B). Fitting curves for IM-II and PLM are shown in red and green, respectively. (C) The top 20 best-fitting incidence curves as measured by Akaike Information Criterion (AIC) for IM-II. (D and E) Universal scaling functions for all cancers with defined pivot ages (84 out of 101 cancer types) plotted in gray with the top 20 incidence curves highlighted. Data shown for both genders (D) and gender-separated data (E), with dotted lines showing the model predictions for IM-I and IM-II. The gender-separated curves are fitted with higher independently determined values for α in males than females, reflecting the gender bias in T cell production (Methods). A purely exponential incidence curve would correspond to a pivot age of negative infinity, and therefore, for the purposes of plotting, we set a minimum pivot age of −50 y. Models are fitted only for ages greater than 18 y. Error bars show 95% CIs for all diseases.
Fig. 3. Cancer incidence. Log-linear plots of incidence (per 100,000 person-years). Data taken from SEER (11). (A and B) Some cancer types rise exponentially fitting IM-I (A), while some cancer types rise like power laws, although can still be fit by IM-II (B). Fitting curves for IM-II and PLM are shown in red and green, respectively. (C) The top 20 best-fitting incidence curves as measured by Akaike Information Criterion (AIC) for IM-II. (D and E) Universal scaling functions for all cancers with defined pivot ages (84 out of 101 cancer types) plotted in gray with the top 20 incidence curves highlighted. Data shown for both genders (D) and gender-separated data (E), with dotted lines showing the model predictions for IM-I and IM-II. The gender-separated curves are fitted with higher independently determined values for α in males than females, reflecting the gender bias in T cell production (Methods). A purely exponential incidence curve would correspond to a pivot age of negative infinity, and therefore, for the purposes of plotting, we set a minimum pivot age of −50 y. Models are fitted only for ages greater than 18 y. Error bars show 95% CIs for all diseases.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

Sorted by citations

Items 201–300 of 362

Related

See all

Metadata

Authors
Palmer, S., Albergante, L., Blackburn, C. C., & Newman, T. J.
Affiliations
  • University of Dundee (GB)
  • Inserm (FR)
  • MRC Centre for Regenerative Medicine (GB)
Corresponding author
  • Palmer, Sam
  • Newman, T. J.
ORCID
Venue
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences
Published
2018-02-05
Volume
115
Issue
8
Pages
1883-1888
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
DOI
10.1073/pnas.1714478115
PMC
PMC5828591
OpenAlex
W2788857602
Cited by
364
References
45
Citations by year
2026: 51 · 2025: 53 · 2024: 45 · 2023: 43 · 2022: 37 · 2021: 36 · 2020: 56 · 2019: 26 · 2018: 17
FWCI
15.04
Type
journal article
Language
en
Open access
Licence
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion, cc-by-nc-nd)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc-nd)
Funders
  • SULSA (U54 CA143682)
  • EC | Seventh Framework Programme (602587)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Physical Sciences › Computer Science › Artificial Intelligence › Artificial Immune Systems Applications
Keywords
thymic involution, immunosenescence, cancer incidence, infectious disease incidence, power law model, mutation accumulation, aging
MeSH terms
Aging, Female, Humans, Male, Models, Biological, Mutation, Neoplasms, Thymus Gland, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review